Treatment of intraarticular osteoarthritis of the knee with hylan G-F 20: comment on the article by Brandt et al.
Parenti
D
D
Murray
C W
CW
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D003432:Cross-Linking Reagents; D004311:Double-Blind Method; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D007270:Injections, Intra-Articular; D007719:Knee Joint; D020370:Osteoarthritis, Knee / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy; D013582:Synovial Fluid / Q000502:physiology; D016896:Treatment Outcome; D014783:Viscosity
D018501:Antirheumatic Agents; D003432:Cross-Linking Reagents; C049816:hylan; D006820:Hyaluronic Acid